(Q42439235)

31 October 2017

Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. (English)

1 reference

31 October 2017

Michael T Heneka

1

1 reference

31 October 2017

Vitaliy Gavrilyuk

2

1 reference

31 October 2017

Gary E Landreth

3

1 reference

31 October 2017

M Kerry O'Banion

4

1 reference

31 October 2017

Guy Weinberg

5

1 reference

31 October 2017

Douglas L Feinstein

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Journal of Neurochemistry

31 October 2017

1 reference

31 October 2017

85

1 reference

31 October 2017

2

1 reference

31 October 2017

387-398

1 reference

Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter

31 October 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01694.X

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01694.X

Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01694.X

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01694.X

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01694.X

10.1046/J.1471-4159.2003.01694.X

21 January 2018

Identifiers

DOI

1 reference

31 October 2017

1 reference